• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫腺肌病患者中CA125相关的活化部分凝血活酶时间及凝血酶时间降低

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis.

作者信息

Yang Fanchun, Wang Qingying, Ma Rui, Deng Fangzhen, Liu Jie

机构信息

Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

出版信息

J Multidiscip Healthc. 2024 Jan 16;17:251-261. doi: 10.2147/JMDH.S435365. eCollection 2024.

DOI:10.2147/JMDH.S435365
PMID:38250313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10799626/
Abstract

OBJECTIVE

Adenomyosis patients are in a hypercoagulable state, and studies have shown that carbohydrate antigen125 (CA125) may relate to the hypercoagulability and thrombosis of patients with adenomyosis, but there is still a lack of clarity regarding the changes in CA125-related coagulation indicators. This study was to explore the changes and influencing factors of CA125-related coagulation parameters in patients with adenomyosis.

METHODS

Retrospective observational study conducted on 200 patients with adenomyosis (AM group), 240 patients with uterine leiomyoma (LM group) and 81 patients with cervical intraepithelial neoplasia (CIN)-III (control group), of which the coagulation parameters were detected by clinical blood sample collection and statistical method analysis and informed consent was obtained.

RESULTS

The level of CA125 in the AM group was significantly higher than that in the LM group and control group. However, thrombin time (TT) shortened in the AM group when compared with the LM and control group. Activated partial thromboplastin time (APTT) in the AM group was shorter than in the control group. Multivariate logistic regression analysis found that adenomyosis was associated with CA125 level (OR=323.860, 95% CI 90.424-1159.924, P<0.001), APTT (OR=1.295, 95% CI 1.050-1.598, P=0.016), TT (OR=0.642, 95% CI 0.439-0.938, P=0.022), menorrhagia (OR=7.363, 95% CI 2.544-21.315, P<0.001), dysmenorrhea (OR=22.590, 95% CI 8.185-62.347, P<0.001). Correlation analysis revealed that APTT (r= -0.207) and TT (r = -0.174) were negatively correlated with the level of CA125.

CONCLUSION

The shortening of CA125-related APTT and TT indicates that it is meaningful to detect coagulation parameters of patients with elevated CA125 levels early, dysmenorrhea and menorrhagia, and maybe further discover the hypercoagulability and prevent the occurrence of thrombus in adenomyosis.

摘要

目的

子宫腺肌病患者处于高凝状态,研究表明糖类抗原125(CA125)可能与子宫腺肌病患者的高凝状态及血栓形成有关,但CA125相关凝血指标的变化仍不明确。本研究旨在探讨子宫腺肌病患者CA125相关凝血参数的变化及影响因素。

方法

对200例子宫腺肌病患者(腺肌病组)、240例子宫肌瘤患者(肌瘤组)和81例宫颈上皮内瘤变III级患者(对照组)进行回顾性观察研究,通过采集临床血样检测凝血参数并进行统计学方法分析,且均获得知情同意。

结果

腺肌病组CA125水平显著高于肌瘤组和对照组。然而,与肌瘤组和对照组相比,腺肌病组凝血酶时间(TT)缩短。腺肌病组活化部分凝血活酶时间(APTT)短于对照组。多因素logistic回归分析发现,子宫腺肌病与CA125水平(OR = 323.860,95%CI 90.424 - 1159.924,P < 0.001)、APTT(OR = 1.295,95%CI 1.050 - 1.598,P = 0.016)、TT(OR = 0.642,95%CI 0.439 - 0.938,P = 0.022)、月经过多(OR = 7.363,95%CI 2.544 - 21.315,P < 0.001)、痛经(OR = 22.590,95%CI 8.185 - 62.347,P < 0.001)有关。相关性分析显示,APTT(r = -0.207)和TT(r = -0.174)与CA125水平呈负相关。

结论

CA125相关的APTT和TT缩短表明,早期检测CA125水平升高、痛经和月经过多患者的凝血参数具有意义,可能进一步发现高凝状态并预防子宫腺肌病中血栓的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/b951e4af90a2/JMDH-17-251-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/dee3ca6dbe51/JMDH-17-251-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/328d6a74b6e1/JMDH-17-251-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/ff5340a1ea95/JMDH-17-251-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/b951e4af90a2/JMDH-17-251-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/dee3ca6dbe51/JMDH-17-251-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/328d6a74b6e1/JMDH-17-251-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/ff5340a1ea95/JMDH-17-251-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb6/10799626/b951e4af90a2/JMDH-17-251-g0004.jpg

相似文献

1
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis.子宫腺肌病患者中CA125相关的活化部分凝血活酶时间及凝血酶时间降低
J Multidiscip Healthc. 2024 Jan 16;17:251-261. doi: 10.2147/JMDH.S435365. eCollection 2024.
2
Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis.子宫腺肌病患者贫血相关血小板及血浆凝血酶原时间增加。
J Clin Med. 2022 Jul 28;11(15):4382. doi: 10.3390/jcm11154382.
3
[Changes of coagulation function in patients with adenomyosis].[子宫腺肌病患者凝血功能的变化]
Zhonghua Fu Chan Ke Za Zhi. 2022 Mar 25;57(3):179-189. doi: 10.3760/cma.j.cn112141-20211229-00759.
4
[Changes of coagulation function in patients with adenomyosis and its clinical significance].[子宫腺肌病患者凝血功能变化及其临床意义]
Zhonghua Fu Chan Ke Za Zhi. 2020 Nov 25;55(11):749-753. doi: 10.3760/cma.j.cn112141-20200817-00646.
5
Serum CA125 as a biomarker for dysmenorrhea in adenomyosis.血清 CA125 作为子宫腺肌病痛经的生物标志物。
Int J Gynaecol Obstet. 2023 Oct;163(1):131-139. doi: 10.1002/ijgo.14832. Epub 2023 May 12.
6
Relevant detection indicator of prethrombotic state in patients with primary hypertension.原发性高血压患者血栓前状态的相关检测指标
World J Clin Cases. 2023 Aug 26;11(24):5678-5691. doi: 10.12998/wjcc.v11.i24.5678.
7
Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.预测子宫动脉栓塞术后子宫腺肌病治疗反应的相关因素:血清CA125水平及合并的子宫内膜异位症。
Diagn Interv Radiol. 2018 Nov;24(6):364-371. doi: 10.5152/dir.2018.17479.
8
Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis.术后糖类抗原 125 水平正常化与子宫动脉栓塞术治疗子宫腺肌病后治疗失败的相关性。
J Obstet Gynaecol Res. 2023 Nov;49(11):2753-2760. doi: 10.1111/jog.15779. Epub 2023 Aug 23.
9
Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis.子宫腺肌病患者月经过多及子宫体积与下尿路症状的相关性
Chin Med J (Engl). 2017 Jul 5;130(13):1552-1556. doi: 10.4103/0366-6999.208232.
10
[The value of serum CA125 assays in the diagnosis of uterine adenomyosis].血清CA125检测在子宫腺肌病诊断中的价值
Zhonghua Fu Chan Ke Za Zhi. 1996 Oct;31(10):590-3.

引用本文的文献

1
A stacked machine learning-based classification model for endometriosis and adenomyosis: a retrospective cohort study utilizing peripheral blood and coagulation markers.一种基于堆叠机器学习的子宫内膜异位症和子宫腺肌病分类模型:一项利用外周血和凝血标志物的回顾性队列研究。
Front Digit Health. 2024 Sep 10;6:1463419. doi: 10.3389/fdgth.2024.1463419. eCollection 2024.
2
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [Letter].子宫腺肌病患者中CA125相关的活化部分凝血活酶时间及凝血酶时间降低[信函]
J Multidiscip Healthc. 2024 Jan 26;17:405-406. doi: 10.2147/JMDH.S460854. eCollection 2024.

本文引用的文献

1
Successful management of cerebral venous sinus thrombosis due to adenomyosis: Case reports and literature review.成功治疗由子宫腺肌症引起的脑静脉窦血栓形成:病例报告和文献复习。
Clin Neurol Neurosurg. 2023 Jun;229:107726. doi: 10.1016/j.clineuro.2023.107726. Epub 2023 Apr 20.
2
Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma.VIII 因子:创伤中止血和血栓形成的动态调节剂。
Anesth Analg. 2023 May 1;136(5):894-904. doi: 10.1213/ANE.0000000000006356. Epub 2023 Apr 14.
3
The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis.
血小板在子宫腺肌病发病机制和病理生理学中的作用
J Clin Med. 2023 Jan 20;12(3):842. doi: 10.3390/jcm12030842.
4
Diagnostic and prognostic value of coagulation-related factors in endometriosis.凝血相关因子在子宫内膜异位症中的诊断和预后价值
Am J Transl Res. 2022 Nov 15;14(11):7924-7931. eCollection 2022.
5
A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab.使用少量凝血酶对凝血酶时间进行凝块波形分析有助于评估血浆的凝血活性,且不受emicizumab存在与否的影响。
J Clin Med. 2022 Oct 18;11(20):6142. doi: 10.3390/jcm11206142.
6
Adenomyosis-Associated Ischemic Stroke: Pathophysiology, Detection and Management.子宫腺肌病相关性缺血性卒中:病理生理学、检测与管理
Brain Sci. 2022 Oct 20;12(10):1410. doi: 10.3390/brainsci12101410.
7
Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery.术前 CA125 作为超声引导高强度聚焦超声消融术后子宫腺肌病症状复发的危险因素。
Int J Hyperthermia. 2022;39(1):1164-1169. doi: 10.1080/02656736.2022.2107716.
8
Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis.子宫腺肌病患者贫血相关血小板及血浆凝血酶原时间增加。
J Clin Med. 2022 Jul 28;11(15):4382. doi: 10.3390/jcm11154382.
9
[Changes of coagulation function in patients with adenomyosis].[子宫腺肌病患者凝血功能的变化]
Zhonghua Fu Chan Ke Za Zhi. 2022 Mar 25;57(3):179-189. doi: 10.3760/cma.j.cn112141-20211229-00759.
10
The Reevaluation of Thrombin Time Using a Clot Waveform Analysis.使用凝血波形分析对凝血酶时间进行重新评估。
J Clin Med. 2021 Oct 21;10(21):4840. doi: 10.3390/jcm10214840.